Publications by authors named "Daihiko Hakuno"

Article Synopsis
  • Current guidelines recommend starting multiple cardioprotective drugs early for patients with heart failure with reduced ejection fraction, but the best order for administering these drugs is not well-established, indicating a need for personalized treatment plans.
  • The LAQUA-HF trial will compare the effects of long-acting versus short-acting loop diuretics alongside different neurohormonal agents, enrolling 240 patients to assess health status changes over 6 months.
  • Ethical approval has been granted for the trial, ensuring informed consent from participants, with results intended for broader dissemination to the medical community.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify echocardiographic predictors of how significant tricuspid regurgitation (TR) affects heart failure (HF) outcomes, focusing on patients with acute HF.
  • The research analyzed data from 462 patients and found that TR was particularly linked to worse HF outcomes in certain subgroups, especially those with persistent atrial fibrillation, larger tricuspid annular diameter, and specific ranges of left ventricular function measurements.
  • A combination of tricuspid annular diameter and fractional area change was highlighted as a strong predictor of TR’s impact on HF, outperforming other assessment methods.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to understand the combined effects of cardiac and non-cardiac factors on outcomes for patients with acute heart failure (HF), particularly readmissions and all-cause death.
  • Conducted over three years, the research analyzed 451 patients, focusing on variables such as frailty, echocardiographic parameters, and overall health conditions.
  • Findings revealed that certain health indicators, like multi-frailty index scores and pulmonary hypertension, were strong predictors of HF readmission, while high frailty scores predicted overall mortality in specific patient groups.
View Article and Find Full Text PDF

Acute cardiac rupture and adverse left ventricular (LV) remodeling causing heart failure are serious complications of acute myocardial infarction (MI). While cardio-hepatic interactions have been recognized, their role in MI remains unknown. We treated cultured cardiomyocytes with conditioned media from various cell types and analyzed the media by mass spectrometry to identify α1-microglobulin (AM) as an Akt-activating hepatokine.

View Article and Find Full Text PDF
Article Synopsis
  • MicroRNA 33 (miR-33) regulates the ATP-binding cassette transporter A1 (ABCA1), and its absence leads to higher levels of HDL-cholesterol and reduced atherosclerosis.
  • Research shows that in miR-33-deficient mice, there are fewer Ly6C monocytes in the bloodstream and more in the bone marrow, alongside increased myeloid progenitors and reduced cell death in certain stem cells.
  • The study suggests that miR-33 impacts monocyte distribution through two main effects: it enhances the production of inflammatory Ly6C monocytes from hematopoietic stem cells and increases HDL-C levels that help decrease these monocytes in circulation.
View Article and Find Full Text PDF

Aims: Recent studies have shown that serum microRNA (miR) abundance is informative for the diagnosis or prognosis of heart failure. However, the dynamics and kinetics of miRs in acute heart failure are largely unknown. Serial measurement and analysis of serum miRs changes in individuals along their therapeutic course could reduce inter-individual variation and should detect potentially important serum miRs related to disease mechanisms.

View Article and Find Full Text PDF

Background: Despite recent progress with drug-eluting stents, restenosis and thrombosis after endovascular intervention are still major limitations in the treatment of cardiovascular diseases. These problems are possibly caused by inappropriate inhibition of neointimal formation and retardation of re-endothelialization on the surface of the stents. miR-126 has been shown to have the potential to enhance vascular endothelial cell proliferation.

View Article and Find Full Text PDF

Rationale: Heart failure and atherosclerosis share the underlying mechanisms of chronic inflammation followed by fibrosis. A highly conserved microRNA (miR), miR-33, is considered as a potential therapeutic target for atherosclerosis because it regulates lipid metabolism and inflammation. However, the role of miR-33 in heart failure remains to be elucidated.

View Article and Find Full Text PDF

There have been very few studies on serum biomarkers associated with hypertension in disaster situations. We assessed biomarkers associated with disaster-related hypertension (DRH) due to the Great East Japan Earthquake of March 2011.We collected blood samples from members of the Japan Self Defense Forces (JSDF) (n = 77) after completing disaster relief operations.

View Article and Find Full Text PDF

Background: Recently, it has been reported that specific microRNA (miRNA) levels are elevated in serum and can be used as biomarkers in patients with cardiovascular diseases. However, miRNAs expression profiles and their sources in pericardial fluid (PF) are unclear.

Methods And Results: The purpose of this study was to identify the levels of miRNAs in PF in relation to those in the serum in patients undergoing cardiac surgery.

View Article and Find Full Text PDF

Background: The heart has close interactions with other organs' functions and concomitant systemic factors such as oxidative stress, nitric oxide (NO), inflammation, and nutrition in systolic heart failure (HF). Recently, plasma amino acid (AA) profiling as a systemic metabolic indicator has attracted considerable attention in predicting the future risk of human cardiometabolic diseases, but it has been scarcely studied in HF.

Methods: Thirty-eight stable but greater than New York Heart Association class II symptomatic patients with left ventricular (LV) ejection fraction <45% and 33 asymptomatic individuals with normal B-type natriuretic peptide (BNP) value were registered as the HF and control groups, respectively.

View Article and Find Full Text PDF

A metabolizing enzyme arginase can decrease nitric oxide (NO) production by competing with NO synthase for arginine as a substrate, but its pathophysiological role in heart failure remains unknown. We aimed to investigate the effect of pharmacological inhibition of arginase on left ventricular function in doxorubicin-induced cardiomyopathy in mice. Doxorubicin administration for 5 weeks significantly increased protein expression levels or activity of arginase in the lungs and liver, and caused moderate increase in arginase 2 expression in the aorta.

View Article and Find Full Text PDF

Background: Endothelial dysfunction causes vasomotor dysregulation and vascular stiffening in addition to structural changes. By influencing NO synthesis, deficiency of l-arginine relative to asymmetric dimethylarginine (ADMA), which is an l-arginine derivative that acts as a competitive NO synthase inhibitor, may lead to the promotion of arterial stiffness. This study investigated the relationship between the l-arginine/ADMA ratio and brachial-ankle pulse wave velocity (baPWV), an indicator of arterial stiffness.

View Article and Find Full Text PDF

Background: Insulin signaling comprises 2 major cascades: the insulin receptor substrate/phosphatidylinositol 3'-kinase/protein kinase B and Ras/Raf/mitogen-activated protein kinase/kinase/ERK pathways. While many studies on the tissue-specific effects of the insulin receptor substrate/phosphatidylinositol 3' -kinase/protein kinase B pathway have been conducted, the role of the other cascade in tissue-specific insulin resistance has not been investigated. High glucose/fatty acid toxicity, inflammation, and oxidative stress, all of which are associated with insulin resistance, can activate ERK.

View Article and Find Full Text PDF

Aim: The anti-oxidant enzyme copper/zinc superoxide dismutase (CuZnSOD) metabolizes superoxide anion (O(2)(-)) in vascular cells. However, the role of CuZnSOD in vascular injury remains poorly understood.

Methods: Using CuZnSOD-deficient (CuZnSOD(-/-)) mice and wild-type (WT) mice, we investigated morphometric changes and the role of O(2)(-) in vascular remodeling after femoral artery injury induced by an external vascular cuff model.

View Article and Find Full Text PDF

The aging of populations worldwide and the habitual consumption of food high in calories and cholesterol have led to recent increases in morbidity from calcific aortic valve disease. At the same time, rupture of the chordae tendineae cordis, which is a component of the mitral valve complex, is one of the major causes of mitral regurgitation. Surgery is the basis of treatment for these diseases, and little is known about their causes and mechanisms.

View Article and Find Full Text PDF